Back to search
FDAFDA · Food and drugs·Recall number D-0603-2021

Sodium Chloride 0.9%, USP, 1000 mL, Mfg by: Fresenius Medical Care North America, Waltham, MA 02451, NDC 46163-0300-10

Published June 16, 2021 · Recall initiated: April 28, 2021

Summary

FDA records drug Class II recall D-0603-2021, published June 16, 2021 and initiated April 28, 2021. Recalling firm: Fresenius Medical Care Holdings, Inc.; Status: Terminated; Reported quantity: 48 cases; Lot: Lot #: 20NG02095, Exp. Date October 2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Temperature Abuse: Product exposed to temperature outside specified limits.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Medical Care Holdings, Inc.
Distributor
Nationwide within the United States
Lot
Lot #: 20NG02095, Exp. Date October 2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sodium Chloride 0.9%, USP, 1000 mL, Mfg by: Fresenius Medical Care North America, Waltham, MA 02451, NDC 46163-0300-10 recalled?

Yes. FDA published recall D-0603-2021 on June 16, 2021. Reported hazard: Temperature Abuse: Product exposed to temperature outside specified limits.

What should I do if I have this product?

Voluntary: Firm initiated · Letter